70.61 USD
↘ 0.80 (1.12%)AT CLOSE (AS OF 07:31 PM EDT)
Tarsus Pharmaceuticals, Inc. Common Stock
TARSNASDAQ • USD
Market: CLOSED
Tarsus Pharmaceuticals, Inc. Common Stock (TARS) trades at $70.61 per share. The technical outlook is "Buy" and the fundamental picture shows "Neutral". Notable factors include a robust Altman Z-Score, negative Return on Equity and a bearish Death Cross on the long-term moving averages. Valuation-wise, the stock is priced at a premium — multiples like P/E and EV/EBITDA sit above sector averages.
Technical & fundamental data as of Aug 26, 2026.
Open?$71.10
High?$71.15
Low?$69.77
Prev. Close?$71.45
Volume?611.5K
Avg. Volume?797.9K
VWAP?$70.74
Rel. Volume?0.77x
Bid / Ask
Bid?$57.07 × 200
Ask?$76.32 × 100
Spread?$19.25
Midpoint?$66.70
Valuation & Ratios
Market Cap?3.1B
Shares Out?43.9M
Float?37.2M
Float %?86.4%
P/E Ratio?N/A
P/B Ratio?8.94
EPS?-$1.07
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Tarsus Pharmaceuticals Inc is a commercial-stage biopharmaceutical company focused on the development and commercialization of therapeutics, starting with eye care. The company is focused on the development and commercialization of first-in-class therapeutic candidates to provide treatment for ophthalmic conditions. The company's candidate XDEMVY is a novel investigational eye drop to treat blepharitis caused by the infestation of Demodex mites, referred to as Demodex blepharitis. TP-04 for the potential treatment of ocular rosacea and TP-05 for potential Lyme disease prophylaxis and community malaria reduction.
Employees
370
Market Cap
3.1B
Industry
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Website
Listed
2020-10-16
Address
15440 LAGUNA CANYON ROAD
IRVINE, CA 92618
Phone: (949) 409-9820
IRVINE, CA 92618
Phone: (949) 409-9820
Technical OutlookBuy
Strong SellNeutralStrong Buy
Long-Term (Tide)?▲ Bullish(+2/3)
Medium-Term (Wave)?▲ Bullish(+2/3)
Short-Term (Ripple)?▼ Bearish(-2/3)
MA Alignment?Mixed
Full Technical Analysis →Fundamental OutlookNeutral
Strong SellNeutralStrong Buy
F-Score?23
Z-Score?100
Momentum?94
Short Sent.?45
Piotroski F-Score?3/9Weak
Altman Z-Score?7.49Safe
Confidence?57%Low
Short InterestHigh
Short % of Float?16.14%High
Short Interest?6.0M
Days to Cover?7.5
Free Float37.2M
Avg Daily Volume801.1K
Settlement Date2026-08-14
Financial Health
Current Ratio?3.20Strong
Quick Ratio?3.17Strong
Cash Ratio?1.16Strong
Debt/Equity?0.21Low
ValuationFAIRLY VALUEDvs 1 peers + S&P 500
Score60/100
P/E?N/A▾
P/B?8.94HIGH▾
Peers100
S&P21
P/S?5.11FAIR▾
Peers100
S&P28
P/FCF?55.4PRICEY▾
Peers100
S&P9
EV/EBITDA?-57.4CHEAP▾
S&P97
EV/Sales?4.90FAIR▾
Peers100
S&P37
Returns & Efficiency
ROE?-13.5%WEAK▾
S&P9
ROA?-7.7%WEAK▾
S&P3
Cash Flow & Enterprise
FCF?$56.0M
Enterprise Value?$3.0B
Fundamentals ratios updated end of day